中央区变应性疾病与鼻息肉型慢性鼻窦炎其他亚型的手术结局比较
该回顾性研究纳入132例接受初次内镜鼻窦手术的鼻息肉型慢性鼻窦炎患者,比较中央区变应性疾病(CCAD)与其他亚型(AERD、AFRS、CRSwNP NOS)的术后结局。结果显示CCAD患者息肉复发和修正手术率显著低于其他亚型,提示CCAD患者术后获益更持久。
要点
- CCAD患者息肉复发率显著低于其他CRSwNP亚型(p=0.003)。
- CCAD患者修正ESS率显著低于AFRS和CRSwNP NOS(p=0.03)。
- CRSwNP NOS患者抗生素使用多于CCAD和AFRS患者。
核心结论
- CCAD患者术后息肉复发和修正ESS率显著低于其他CRSwNP亚型,提示ESS及术后药物治疗在CCAD中获益持久。
主要发现
- CCAD患者息肉复发频率低于预期,AFRS患者高于预期(p=0.003;phi 0.32)。
- CCAD患者修正ESS频率低于预期,AFRS和CRSwNP NOS高于预期(p=0.03;phi 0.26)。
- CRSwNP NOS患者总抗生素疗程多于CCAD(p=0.01;eta-squared 0.09),每月抗生素疗程多于AFRS(p=0.03;eta-squared 0.07)。
- 各组随访指标(就诊次数、总月数、每月就诊次数)无显著差异。
关键数值与推荐
- 息肉复发:CCAD低于预期,AFRS高于预期(p=0.003;phi 0.32)。
- 修正ESS:CCAD低于预期,AFRS和CRSwNP NOS高于预期(p=0.03;phi 0.26)。
- 总抗生素疗程:CRSwNP NOS多于CCAD(p=0.01;eta-squared 0.09)。
- 每月抗生素疗程:CRSwNP NOS多于AFRS(p=0.03;eta-squared 0.07)。
临床怎么用
- 对于CCAD患者,初次ESS及规范术后药物治疗可能带来较低的息肉复发和修正手术风险。
- 对其他CRSwNP亚型(尤其AFRS和CRSwNP NOS)应加强术后随访和药物管理。
- CRSwNP NOS患者可能需关注抗生素使用情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Central compartment atopic disease (CCAD) is a variant of chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) characterized by polypoid changes of the superior nasal septum, middle (MT), and/or superior turbinates (ST). This study evaluates surgical outcomes in patients with CCAD compared with other CRSwNP subtypes. METHODS: Retrospective analysis was performed at Emory University from May 2012 to November 2019. Patients undergoing primary endoscopic sinus surgery (ESS) for CCAD, aspirin-exacerbated respiratory disease (AERD), allergic fungal rhinosinusitis (AFRS), and CRSwNP not otherwise specified (CRSwNP NOS) were included consecutively, beginning with the earliest date of CCAD patient. Outcome measures included polyp recurrence, revision ESS, oral steroid use, and oral antibiotic use. Pearson chi-square and univariate analysis of variance (ANOVA) were performed for group comparisons. RESULTS: Data was collected for 132 patients (CCAD = 38, AERD = 20, AFRS = 37, CRSwNP NOS = 37; 58 females, mean age 42.9 years [range, 13-85 years]). CCAD patients demonstrated polyp recurrence less frequently than expected, whereas AFRS patients had polyp recurrence more frequently than expected (p = 0.003; phi 0.32). CCAD patients underwent revision ESS less frequently than expected; AFRS and CRSwNP NOS underwent revision ESS more frequently than expected (p = 0.03; phi 0.26). CRSwNP NOS patients received more total antibiotic courses than those with CCAD (p = 0.01; eta-squared 0.09) and more courses of antibiotics per month than those with AFRS (p = 0.03; eta-squared 0.07). There was no significant difference in follow-up measures across groups (number of visits, total months, or visits per month). CONCLUSION: Rates of polyp recurrence and revision ESS were significantly lower in CCAD patients compared with patients with other CRSwNP subtypes, suggesting durable benefit of ESS and postoperative medical therapy in CCAD patients.
引用
- Steehler AJ, Vuncannon JR, Wise SK, et al. Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021. PMID: 34076353. doi:10.1002/alr.22819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。